Rebekah Lee, PharmD, BCPS

U.S. Food and Drug Administration, Silver Spring, MD, USA

Poster(s):

• (B-105) Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET